Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
MDA can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. Compulsive redosing may occur due to its euphoria-inducing effects, with a strong desire to repeat the experience commonly reported when coming down.
MDA is generally not considered physically addictive, though cravings and withdrawal effects may occur if chronic users suddenly stop usage.
A 450-500 mg intravenous injection of MDA resulted in death in one documented case (Harold Blauer, 1953). Deaths from oral use are rare; assuming similar risk to MDMA, approximately 2 per 100,000 users experience extreme negative reactions resulting in death. In overdose cases, death is usually caused by cardiac effects and subsequent hemorrhaging in the brain.
MDA is known to be more neurotoxic than MDMA, with estimates suggesting it may be approximately five times as neurotoxic; this is a primary safety concern with frequent use, high doses, or elevated body temperature during use.
MDA is reported to be hepatotoxic, though liver toxicity from use is considered rare.
Acute toxicity and overdose can cause dangerous cardiovascular strain including dramatically increased blood pressure and heart rate; death in overdose cases is usually caused by cardiac effects and subsequent hemorrhaging in the brain.
Psychological crisis requiring hospitalization, including psychotic episodes and severe panic attacks, is possible but rare. Regular use may lead to schizophrenia-like symptoms. Derealization can occur temporarily after a strong experience and may persist in cases of misuse.
Seizures are a rare effect but can occur in people predisposed to them, especially when taking heavier-than-recommended doses or while in physically taxing conditions such as dehydration, fatigue, or undernourishment. Convulsions are listed among symptoms of acute toxicity and overdose.
MDA was first synthesized by German chemists Carl Mannich and W. Jacobsohn in 1910, though its psychoactive properties remained unknown for two decades. The compound's mind-altering effects were discovered through self-experimentation by American chemist Gordon Alles in July 1930, who administered…
UN Convention on Psychotropic Substances 1971 (Schedule I)
Classified as a controlled substance under national drug legislation. Unlicensed possession, production, and distribution are prohibited.
Listed as a controlled substance under Brazilian drug legislation. Production, distribution, and possession are illegal.
Classified as a stupéfiant, designating it as a recognized drug of abuse under French law. Possession, purchase, sale, and manufacture are illegal.
Listed in Tabella I of the controlled substances tables (Tabelle delle sostanze stupefacenti e psicotrope). Possession, purchase, and sale are illegal.
Classified as a Class A controlled drug under New Zealand's Misuse of Drugs Act. This represents the most restrictive category with the most severe penalties.
Specifically named as a controlled substance under Verzeichnis D of the Swiss narcotics scheduling system.
Designated as a Schedule I controlled substance under the Controlled Substances Act. Manufacturing, purchasing, possessing, or distributing without DEA authorization is a federal crime.
Prohibited under the Suchtmittelgesetz (SMG), the Austrian Narcotics Act. Possession, production, and sale without authorization are criminal offenses.
Added to Schedule I of the Controlled Drugs and Substances Act in 2012. Manufacturing, trafficking, and possession without authorization carry significant criminal penalties.
Controlled under Anlage I of the Betäubungsmittelgesetz (Narcotics Act) since September 1, 1984. Manufacturing, possession, import, export, purchase, sale, and dispensing without a license are prohibited.
Prohibited substance under Dutch drug legislation. Possession, production, and sale are criminal offenses.
Listed as a Schedule I prohibited substance under Russian Federation drug control legislation. No medical use is recognized.
Controlled as a Class A substance under the Misuse of Drugs Act 1971. Selling, buying, or possessing without a license is illegal, with Class A offenses carrying the most severe penalties.
17 sources cited